Drug-Device Combination Products Market Report, Size, Share, Key Companies Analysis, Future Trends and Industry Growth Research Report till 2027
A comprehensive overview of the Drug-Device Combination Products market is recently added by UnivDatos Market Insights to its humongous database. The Drug-Device Combination Products market report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the drug-device combination products market. The Drug-Device Combination Products Market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the drug-device combination products market at the global and regional levels. The Global Drug-Device Combination Products Market is expected to grow significantly by 2027.
Market Overview
The increasing demand
for portable medical devices has stimulated the demand for technologically
advanced drug-device combination products. These devices are used in patients who
are suffering from chronic diseases such as cancer, diabetes, cardiovascular
diseases etc. For instance, in February 2020, the BD (Becton, Dickinson, and
Company), a leading global medical technology company, announced their
completion of a 50-subject human clinical trial with the “BD Libertas Wearable
Injector”. Moreover, the surge in the home-based
care service is also driving the market growth. According to one of the top global data bases,
health tech has seen strong investment growth in 2019, claiming a record USD
7.8 billion for virtual care investment. For
instance, “Amwell” a healthcare firm, accounted for considerable funding, raised
almost US$ 500 million in 2020, from investors including Allianz
X and Philips. Homebased healthcare provides faster care to
the patients and helps them to avoid hospitals.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=6406
COVID-19 Impact
During the COVID-19 pandemic, majority
of the pharma company have experienced huge losses due to the suspension of
clinical trials. Also, in the short term, the pandemic has created an immediate
need to address active supply chain disruptions. For instance, according
to the Jabil survey 2020, across seven industries and the 715-supply chain
decision-makers, all have suffered huge financials losses due to supply chain
disruption. The hardest hit is the retail and healthcare sectors. Healthcare
sector experienced the highest percentage of respondents who stated their
companies have experienced negative financial impact greater than US$ 500
million from March to August in 2020.
Global Drug-Device Combination Products Market report is studied
thoroughly with several aspects that would help stakeholders in making their
decisions more curated.
By Product, the market is primarily bifurcated into:
•
Drug-eluting stent
•
Infusion pump
•
Photosensitizers
•
Prefilled syringe
•
Wound care Combination Products
•
Orthopaedic Combination Products
•
Drug-eluting balloon
•
Inhalers
•
Transdermal delivery system
•
Others
The Transdermal delivery
system segment generated the highest revenue in 2020 and the market is expected
to grow at a significant rate during the forecast period.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=6406
By Application, the market is
primarily bifurcated into:
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial
application
• Others
The Cardiovascular
disease segment accounted for the major revenue portion in 2020 and the sector is
anticipated to observe lucrative growth in the upcoming years.
By Distribution Channel, the market is
primarily bifurcated into:
•
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
The Retail Pharmacies segment accounted for the major revenue portion in 2020. The sector is anticipated to observe considerable growth in
the upcoming years.
By End-user, the market is primarily bifurcated into:
·
Ambulatory Surgery
Centre
·
Home Care Setting
·
Others
The Hospital & Clinic segment is anticipated to observe lucrative growth in 2020.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=6406
Drug-Device Combination Products
market Geographical Segmentation Includes:
·
North America (US, Canada, and Rest of
North America)
·
Europe (Germany, UK, Italy, France,
Spain, and Rest of Europe)
·
Asia-Pacific (China, Japan, India,
Australia, and
Rest of Asia-Pacific)
·
Rest of the World
Based
on the estimation, North America constitutes a major market for the drug-device
combination products industry and generated maximum
revenue in 2020 owing to the presence of major companies and
healthcare infrastructure with the highest rate of chronic diseases across the
world.
The
major players targeting the market includes
·
Medtronic PLC
·
Abbott Laboratories
- Smith &
Nephew plc
- Boston Scientific
Corporation
- GlaxoSmithKline
plc
- Becton Dickinson
and Company
- Johnson &
Johnson
- Novartis AG
- Bayer AG
- Baxter International, Inc.
Competitive Landscape
The degree of competition among prominent global companies has been
elaborated by analyzing several leading key players operating worldwide. The
specialist team of research analysts sheds light on various traits such as
global market competition, market share, most recent industry advancements,
innovative product launches, partnerships, mergers, or acquisitions by leading
companies in the ventricular assist devices market. The major players have been
analyzed by using research methodologies for getting insight views on global
competition.
For more informative
information, please visit us @ https://univdatos.com/report/drug-device-combination-products-market/
Key questions resolved through this analytical market research report
include:
•
What are the latest trends, new
patterns, and technological advancements in the drug-device
combination products market?
•
Which factors are influencing
the ventricular assist dev drug-device combination products market over the forecast period?
•
What are the global challenges,
threats, and risks in the drug-device combination products market?
•
Which factors are propelling
and restraining the drug-device combination products market?
•
What are the demanding global
regions of the drug-device combination products market?
•
What will be the global market
size in the upcoming years?
•
What are the crucial market
acquisition strategies and policies applied by global companies?
We understand the requirement of different businesses, regions, and
countries, we offer customized reports as per your requirements of business
nature and geography. Please let us know If you have any custom needs.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home